Mostrar el registro sencillo del ítem
dc.contributor.author
Laconi, Myriam Raquel
dc.contributor.author
Casteller, Guillermo
dc.contributor.author
Gargiulo, Pascual Angel
dc.contributor.author
Bregonzio Diaz, Claudia
dc.contributor.author
Cabrera Kreiker, Ricardo Jorge
dc.date.available
2022-10-05T14:18:58Z
dc.date.issued
2001-04
dc.identifier.citation
Laconi, Myriam Raquel; Casteller, Guillermo; Gargiulo, Pascual Angel; Bregonzio Diaz, Claudia; Cabrera Kreiker, Ricardo Jorge; The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats; Elsevier Science; European Journal of Pharmacology; 417; 1-2; 4-2001; 111-116
dc.identifier.issn
0014-2999
dc.identifier.uri
http://hdl.handle.net/11336/171955
dc.description.abstract
The behavioural display in the plus-maze, an established experimental model of anxiety, was studied in rats injected into the lateral brain ventricle (i.c.v.) with the neurosteroid 3α-hydroxy-5α-pregnan-20-one (allopregnanolone). Female rats under different gonadal hormonal status were chosen. Allopregnanolone enhanced exploration of the open arms in both estrous rats and ovariectomized estrogen and progesterone primed rats. No effect was observed in diestrous 1 and ovariectomized not-primed rats. In all cases, the plus-maze locomotor-exploratory behaviour was not affected by allopregnanolone. The GABAA receptor antagonist, bicuculline (9.8 μM i.c.v.) reversed the allopregnanolone action in the ovariectomized primed rats. When bicuculline was injected i.c.v. in conjunction with allopregnanolone, the anxiogenic effect of bicuculline was reversed by the highest dose (25 μM) of allopregnanolone only. These results suggest that allopregnanolone exerts an anxiolytic action interacting with the GABAA receptor in an estrogen-dependent manner. © 2001 Elsevier Science B.V.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier Science
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
ALLOPREGNANOLONE
dc.subject
ANXIETY
dc.subject
ESTROUS CYCLE
dc.subject
GABAA RECEPTOR
dc.subject
NEUROSTEROID
dc.subject.classification
Neurociencias
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2021-12-03T20:25:53Z
dc.journal.volume
417
dc.journal.number
1-2
dc.journal.pagination
111-116
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Laconi, Myriam Raquel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
dc.description.fil
Fil: Casteller, Guillermo. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina
dc.description.fil
Fil: Gargiulo, Pascual Angel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina
dc.description.fil
Fil: Bregonzio Diaz, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina
dc.description.fil
Fil: Cabrera Kreiker, Ricardo Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina
dc.journal.title
European Journal of Pharmacology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0014299901008652
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/S0014-2999(01)00865-2
Archivos asociados